cognitive cybersecurity intelligence

News and Analysis


Nine biotech companies to watch in 2024

Nine biotech companies are set to make significant advances in 2024. Aiolos Bio, focusing on treatments for respiratory and inflammatory diseases, plans its phase 2 clinical trial. Capstan Therapeutics is developing treatments with precise cell engineering. Carisma Therapeutics is developing cancer treatments. Cellarity uses AI for drug discovery. Kriya Therapeutics is backed by $600 million for gene therapy development. Maze Therapeutics uses genetics to develop precision medicines. Quotient Therapeutics uses advanced sequencing technology. ReNAgade Therapeutics, with $300 million in funding, develops RNA medicines. OrsoBio focuses on therapies for severe metabolic disorders.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts